-
Understanding 340B Programs: An Interview with Antonio Ciaccia, CEO, 46brooklyn Research
- 2024/04/25
- 再生時間： 47 分
- ポッドキャスト
-
サマリー
あらすじ・解説
In this episode, we explore the 340B Drug Pricing Program, an essential yet complex component of the American drug supply landscape that aims to enable healthcare entities to offer more affordable medication to underserved populations. We interview Antonio Ciaccia, a drug pricing and 340B expert who provides an in-depth look at how the program works, its financial incentives, and how stakeholders have exploited this well-intentioned program, all to the detriment of patients.
- Antonio Ciaccia, President, 3 Axis Advisors and CEO, 46brooklyn Research, an Ohio non-profit Corporation
- 46brooklyn
- Ohio Pharmacist Association
- 3 Axis Advisors
- Medicaid
- 340B Program
- 340B Litigation
- 340 Eligibility, HRSA
- Covered Entities
- Medicaid Drug Rebate Program
- Obamacare
- Indian Health Service
- "Money from Sick People," Report from 46Brooklyn
- Medicare
- Pharmacy Benefit Managers (PBMs)
- Jamie Robinson, Health Economist
Medical terminology referenced in this episode:
- Novolog
Questions or comments?
Email us at comments@prescriptionforbetteraccess.com.
Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.